Vanrx's aseptic filling technology can speed up the design, build and validation process to start a filling facility.

Starting an aseptic filling facility

This is the right time to start an aseptic filling facility. There’s never been more demand for filling of sterile injectables, including biologics, orphan drugs and personalized medicines. Choosing the right filling technology can help speed up the design / build / validation processes and enhance drug product quality for the patients you serve.

 

Who uses Vanrx aseptic filling machines?

Leading biopharma companies using Vanrx Aseptic Filling Workcells include Singota Solutions, ADMA Biologics, Amgen, Emergent BioSolutions, FUJIFILM Diosynth Biotechnologies, Roche / Genentech, Moderna, WuXi Biologics, and Wildlife Pharmaceuticals.

Vanrx aseptic filling workcells have small footprints and need just a Grade C background.

Simplified facility design

Aseptic Filling Workcells have small footprints and need a Grade C background, so you can have a smaller, less expensive cleanroom to house a machine. They have simple utility requirements too–just power, compressed air and an exhaust.

Short lead times of Vanrx Aseptic Filling Workcells help customers get their drug products to market faster.

Speed to market

Vanrx customers typically complete their equipment validation 12-15 months from their purchase order for an SA25 and 6 months for the Microcell. That’s very fast. The standard design of Aseptic Filling Workcells, plus a supporting ecosystem of single-use consumables and ready-to-use containers and closures, smooths your path to GMP manufacturing.

All Vanrx machines support 30 minute or less decontamination times for increased flexibility.

Flexibility

Flexibility means being able to fill different vial, syringe and cartridge formats without wasting time? Customers can change over to a new format in less than an hour, and all Vanrx machines support 30-minute or less decontamination times. With single-use consumables, you’re agile, but without the risk of cross-contamination.